GlassScriptPhysician profile
William G Merriam
NPI 1912043258
$7,657.91
in general payments reported to CMS, 2019-2025
44 companies · $2,508 in 2025
The $2,508 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,254 · 2020: $483 · 2021: $264 · 2022: $437 · 2023: $878 · 2024: $1,834 · 2025: $2,508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,388 · Travel and Lodging: $797 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,387.91 |
| Travel and Lodging | $797.04 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,389.49 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Dendreon Pharmaceuticals LLC | $831.07 | 2019-2025 | Provenge |
| Pfizer INC. | $632.39 | 2019-2025 | |
| Teleflex LLC | $524.13 | 2021-2025 | Urolift, Barrigel |
| Janssen Biotech, INC. | $435.53 | 2019-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $386.23 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $343.36 | 2019-2025 | |
| Astellas Pharma US INC | $322.81 | 2019-2024 | Xtandi, Myrbetriq |
| Abbvie INC. | $267.71 | 2019-2025 | |
| Axonics, INC. | $247.80 | 2022-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $246.96 | 2019-2024 | Lithovue |
| Tolmar, INC. | $176.27 | 2023-2025 | Jatenzo, Eligard |
| Immunitybio, INC. | $168.24 | 2025 | |
| Ferring Pharmaceuticals INC. | $157.83 | 2019-2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $148.93 | 2019-2024 | Keytruda, Lynparza |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Merriam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.